Fellow Health, a company focused on advancing male reproductive health through patient-centric testing solutions, recently achieved a significant milestone of delivering more than 100,000 patient test results since its product launch in 2020, highlighting its power to provide accurate and user-friendly testing for the male reproductive system.
Nearly 1 in 6 couples experience fertility issues worldwide. Fellow Health’s mail-in semen analysis is uniquely designed to help couples find answers while prioritizing patient convenience and accuracy. It is the only mail-in fertility test with peer-reviewed validation data that demonstrates its accurate analysis.
In addition to fertility testing, the company also offers a post-vasectomy test, addressing compliance barriers for the 500,000 men who undergo vasectomies annually in the U.S. and providing a solution for those with limited access to an in-person clinic.
“We have always put scientific rigor first, designing a preservative solution that maintains sample integrity and ensures results are as accurate as if the sample was tested within one hour of being produced,” said Brian Hogan, CEO of Fellow Health. “Our testing approach is backed by extensive scientific research, with over 30 peer-reviewed publications and presentations at leading scientific meetings. This commitment is reflected in the number of patients and clinics that trust us with their reproductive testing.”
“Fellow Health’s testing volume has increased by over 50 percent year-to-date from 2023, now serving more than 1,500 clinical practices, including 11 of the top 15 hospitals in the U.S. I am immensely proud of our team’s progress in transforming patient health and driving the company’s growth,” said Will Matthews, founder of Fellow Health. “We are eager to continue pushing the boundaries of what’s possible in male reproductive health.”
About Fellow Health
Founded in 2018, Fellow Health is a pioneering company dedicated to advancing male reproductive health through innovative and comprehensive mail-in testing solutions. Partnering with top hospitals and urology networks, Fellow Health is the only mail-in fertility test with peer-reviewed validation data. The company partners with more than 1,500 top clinical practices to support the needs of patients seeking reproductive health, processing over 300 patient samples daily through their CLIA-certified lab. Fellow Health has secured funding from leading life sciences and technology investors, including 5AM Ventures, Genoa Ventures, Human Capital, and Mantis Venture Capital.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241031214731/en/
